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Abstract
We report on two large corpora of semantically annotated full-text biomedical research papers created in order to develop information
extraction (IE) tools for the TXM project. Both corpora have been annotated with a range of entities (CellLine, Complex, Developmental-
Stage, Disease, DrugCompound, ExperimentalMethod, Fragment, Fusion, GOMOP, Gene, Modification, mRNAcDNA, Mutant, Protein,
Tissue), normalisations of selected entities to the NCBI Taxonomy, RefSeq, EntrezGene, ChEBI and MeSH and enriched relations
(protein-protein interactions, tissue expressions and fragment- or mutant-protein relations). While one corpus targets protein-protein
interactions (PPIs), the focus of other is on tissue expressions (TEs). This paper describes the selected markables and the annotation
process of the ITI TXM corpora, and provides a detailed breakdown of the inter-annotator agreement (IAA).
1 Introduction
This paper describes two corpora constructed and annotated
for the TXM project. The aim of the TXM project was to
develop tools for assisting in the curation of biomedical re-
search papers. The ITI TXM corpora were used to train and
test machine learning based NLP components which were
interfaced with a curation tool.
There already exist several corpora of annotated biomedi-
cal texts (Section 2), all with individual design and annota-
tion characteristics. The ITI TXM corpora combine a num-
ber of attractive characteristics of such available corpora,
thus making them a valuable resource for NLP research.
We annotated full-text papers since our intended target ap-
plication (the curation tool) worked with such documents.
Furthermore, it has been shown in previous research that
there is valuable information in full-text articles that cannot
be obtained from their abstracts alone (e.g. by Shah et al.,
2003 and McIntosh & Curran, 2007). The markables used
in the ITI TXM corpora included not only a range of named
entities and relations, but also extensive, multi-species nor-
malisation of proteins, genes and other entities, to standard
publicly available databases.1 Furthermore, some of the re-
lations were enriched with additional biomedical informa-
tion enabling finer-grained classification, and connecting
the relations with other entities in the text. At around 200
full-text papers each, the corpora are relatively large in size.
In addition, we will release multiple annotations of many of
the papers, enabling the comparison of different annotators’
views of the corpus. The set of markables chosen for both
corpora arose out of extensive discussions between biolo-
gists managing the curation, and NLP researchers creating
the NLP components. The biologists were consulted to de-
termine what information they wanted to be extracted. At
the same time, their ideas had to be balanced against what
was possible using the state-of-the-art in NLP technology,
and what could be reliably annotated. The final set of mark-
ables resulted out of several iterations of piloting and mea-
surements of IAA.
This paper is organised as follows: after discussing related
1Normalisation refers to the task of grounding a biomedical
term in text to a specific identifier in a referent database. See
Table 3 for the publicly available databases used.
work on biomedical corpus design and annotation in the
next section, a description of how the documents were se-
lected for the corpora is provided in Section 3. An overview
of both corpora, a description of the markables, the annota-
tion process and details of the IAA are presented in full in
Section 4. Finally Section 5 offers some conclusions and
lessons learnt from the annotation project.
2 Related Work
In recent years, there have been numerous efforts in con-
structing and annotating biomedical corpora. Comprehen-
sive lists of publicly available corpora are maintained by
Cohen et al.2 as well as Hakenberg3. This related work
section does not provide an all-inclusive list of biomedical
corpora but rather presents different characteristics of cor-
pus design and annotation illustrated by typical examples.
Existing resources vary in size, type of data, markables and
levels of annotation, the way the annotation is applied, their
distributed formats and their domains. The GENIA cor-
pus (Ohta et al., 2002), for example, is one of the largest
and most widely used data sets in the text mining commu-
nity. It consists of 2,000 Medline abstracts and is manually
annotated with a series of semantic classes defined in the
GENIA ontology. Other corpora are made up of sets of
sentences from biomedical research articles, as is the case
for BioInfer (Pyysalo et al., 2007) and GENETAG (Tanabe
et al., 2005). The latter is a collection of 20,000 Medline
sentences annotated for gene and protein names in one se-
mantic class. Parts of this corpus were used in the BioCre-
AtIvE I and II competitions that, amongst other tasks, en-
abled different text mining research groups to evaluate how
well their systems perform at extracting gene/protein names
from biomedical literature.
Although there have been a series of corpus construction ef-
forts for the purpose of biomedical text mining, only a small
number of groups (e.g. Wilbur et al., 2006 and Krallinger
et al., 2006) report IAA figures. In other words, it is rare
to find information about how consistent two independent
2http://compbio.uchsc.edu/ccp/corpora/
obtaining.shtml
3http://www2.informatik.hu-berlin.de/
˜hakenber/links/benchmarks.html
annotators are when marking up a representative sample of
a data set. The assumption is that the level of IAA pro-
vides insights into how challenging a particular task is to a
human expert, providing an upper bound for an automated
system is and how appropriate the task in itself is. Lu et
al. (2006) show an increase in IAA over time as annota-
tors become more familiar with their task of marking up
GeneRIFs with 31 semantic classes in the protein transport
domain. Figures of IAA also help to determine weaknesses
in the annotation guidelines. Mani et al. (2005) measured
IAA based on a first set of annotation guidelines for mark-
ing up protein names.4 After analysing the annotation dif-
ferences, they revised their guidelines which resulted in an
improvement of IAA in a second annotation round and si-
multaneously in better annotation quality overall. Alex et
al. (2006) have shown that consistency in the annotation
of named entity boundaries is crucial to obtain high accu-
racy for biomedical named entity recognition. The need
for both clear annotation guidelines to achieve such consis-
tency and comprehensive annotation guidelines to capture
complex information in unstructured text data is often high-
lighted (e.g. see Wilbur et al., 2006 and Piao et al., 2007).
Making such guidelines available to the research commu-
nity and publishing figures of IAA is recommended by Co-
hen et al. (2005) who analysed the characteristics of differ-
ent biomedical corpora. They also conclude that distribut-
ing data in standard formats (e.g. XML) is vital to guarantee
high corpus usage.
As mentioned earlier, publicly available corpora differ in
the type of textual data, i.e. a corpus can be made up of
sentences, abstracts or full-text papers. McIntosh & Cur-
ran (2007) and Shah et al. (2003) indicate a clear need
for biological IE from full-text articles. The former study
shows that only a small proportion of identified fact in-
stances appears in abstracts. The latter found that although
abstracts contain the best ratio of keywords, other sections
of articles are a better source of biologically relevant data.
As a result, they advocate IE systems that are tuned to spe-
cific sections. As much of the important information is
not present in the abstract but the main paper, Cohen et
al. (2005) suggest that abstracts and isolated sentences are
inadequate and unsuited to the opportunities that are avail-
able for text mining. Sometimes, the most relevant infor-
mation in a paper is found in figure captions (Shatkay and
Feldman, 2003). Currently, only few available resources
contain full-text publications, one example of such a cor-
pus being FetchProt (2005). Its annotation includes specific
experiments and results, the proteins involved in the exper-
iments and related information. Exploiting such full-text
resources is vital to develop text mining systems that will
be used in practice, e.g. by biologists, clinicians or curators.
Publicly available biomedical corpora also often differ in
their markables and levels of annotation. Some are an-
notated with part-of-speech tags (e.g. GENIA) and named
entities, most often gene/protein names (e.g. GENETAG)
that are sometimes normalised to identifiers (e.g. Fetch-
Prot). In other cases, the annotation includes binary rela-
tions between entities such as PPIs (e.g. AImed described
in Bunescu et al., 2005) or non-binary relations (e.g. BioIn-
fer). Several corpora are distributed with syntactic annota-
tion such as phrase-based or dependency-based structures,
4Mani et al. (2005) refer to IAA as inter-coder reliability.
e.g. BioIE (Kulick et al., 2004), GENIA treebank (2005),
LLL (Nedellec, 2005) and BioInfer.
In this paper, we introduce two large biomedical corpora in
the sub-domains of PPIs and TEs which will be distributed
in one collection as the ITI TXM corpora. Both corpora are
made up of full-text papers that are annotated with a series
of relevant named entities, some of which are normalised.
Furthermore, the annotations include various types of rela-
tions as well as relation attributes and properties (see Sec-
tion 4.2). Domain experts used extensive curation guide-
lines that were devised based on several rounds of piloting
(see Section 4.3). We provide figures of IAA for all types
of semantic annotation for a representative corpus sample
(see Section 4.4). Moreover, the data is distributed in XML
with semantic annotations in standoff format (Carletta et
al., 2005). In the future, the ITI TXM corpora will serve as a
valuable resource to train IE methods for mining facts from
biomedical literature.
3 Document Selection
Document selection for the PPI corpus was performed in
two stages. The initial plan was to annotate only full-text
articles available in XML. Therefore, 12,704 full-text XML
files were downloaded from PubMedCentral OpenAccess.5
The documents were filtered by selecting those articles that
contained at least 1 of 13 terms either directly associated
with PPIs or with biological concepts representative of typ-
ical curation tasks.6 The abstracts and, if necessary, full
texts of the remaining 7,720 documents were all examined
by trained biologists and selected if they contained inter-
actions that were experimentally proven within the paper,
resulting in a total of 213 documents.7 In order to ensure
that enough documents were available for annotation, the
same queries were performed against PubMed and addi-
tional documents were selected from the resulting list using
the same criteria.8 Several of the documents were excluded
from the final set because they were used during the pilot-
ing or were rejected by the annotators as not being suitable
for annotation. The resulting corpus consists of 217 doc-
uments, 133 selected from PubMedCentral and 84 docu-
ments selected from the whole of PubMed.
Document selection for the TE corpus was performed
against PubMed. This was partially to ensure that enough
documents were selected, and partially to address the con-
cern that in practice, many important documents would not
be available in XML and the annotations would be more
representative if they accounted for this reality. The ini-
tial pool of documents was selected from PubMed using
terms designed to capture documents representative of typ-
ical TE and PPI curation tasks.9 The abstracts of the re-
sulting 12,060 documents were randomised and examined
5http://www.pubmedcentral.nih.gov/
The 12,704 articles represented the complete set of available doc-
uments on 17/08/2005.
6The terms were: bind, complex, interact, apoptosis, ubiqui-
tination, mitosis, nuclear envelope, cell cycle, phosphorylation,
glycosylation, signal transduction and nuclear receptors.
7Clinical articles on drug or patient trials were excluded.
8http://www.ncbi.nlm.nih.gov/PubMed/
9The queries were: “Gene Expression Regulation”[MeSH],
Development, “Signal Transduction”[MeSH], “Protein Biosyn-
thesis”[MeSH], “Cell Differentiation”[MeSH], Apoptosis, Mito-
sis, Cell cycle and Phosphorylation
PPI TE
Annotations TRAIN DEVTEST TEST All TRAIN DEVTEST TEST All
1 65 25 35 125 82 34 34 150
2 48 9 8 65 68 7 11 86
3 20 5 2 27 1 0 1 2
Total documents 133 39 45 217 151 41 46 238
Total annotations 221 58 57 336 221 48 59 328
Table 1: Counts of numbers of papers with 1, 2 or 3 annotations in each section of each corpus.
in order by a biologist and selected if they contained men-
tions of the presence or absence of mRNA or protein in any
organism or tissue. A total of 4,327 documents were exam-
ined of which 1,600 were selected for TE annotation. The
TE corpus is comprised of the first 238 of these documents
that were not used during piloting and not rejected by the
annotators.
In both phases, documents were split into TRAIN, DE-
VTEST, and TEST sets in a ratio of approximately 64:16:20
(see Table 1). TRAIN was to be used for training machine
learning models and deriving rules, DEVTEST for testing
during system development, and TEST for testing the final
system. The document selection methods were dictated,
in part, by the requirements of the industrial partner that
assisted in the annotation of the corpora. The terms used
were based on the queries used for selecting documents for
creating commercially viable curated databases. Further-
more, the results of document selection were used to create
training and testing corpora for a document retrieval system
designed to improve the document selection phase. These
corpora will be released at a future date.
4 Corpus Annotation
4.1 Overview
Documents were selected for annotation as described in
Section 3. The full-text papers were downloaded from
PubMed or PubMedCentral either as XML, or as HTML if
the XML version was not available, and then converted to
an in-house XML format using LT-XML2 tools.10 The LT-
XML2 and LT-TTT2 tools were also used to tokenise and in-
sert sentence boundaries into the text (Grover et al., 2006).
From each corpus a random selection of documents was
chosen for double or triple annotation in order to allow cal-
culation of IAA, which is used to track annotation quality
and to provide a measure of the difficulty of the task. The
counts of singly and multiply annotated documents in the
TRAIN, TEST and DEVTEST sections for both corpora are
shown in Table 1. Multiply annotated documents were left
in the corpus and not reconciled to produce a single, gold
standard version. It was found during piloting that recon-
ciliation could be very time-consuming so we decided to
focus our resources on obtaining a larger sample of papers.
During the annotation of the full-text papers, we did not
annotate sections that did not contain any relevant infor-
mation, e.g. contact details and reference sections, HTML
navigational text. Moreover, materials and methods sec-
tions were not annotated on the grounds that they would
be too time-consuming to annotate. The annotators marked
unannotated paragraphs during the annotation so that these
sections could be excluded from training and testing. Based
on the sentence splitting and tokenisation performed during
10http://www.ltg.ed.ac.uk/software/xml/
Entity type PPI TE
CellLine 7,676 —
Complex 7,668 4,033
DevelopmentalStage — 1,754
Disease — 2,432
DrugCompound 11,886 16,131
ExperimentalMethod 15,311 9,803
Fragment 13,412 4,466
Fusion 4,344 1,459
GOMOP — 4,647
Gene — 12,059
Modification 6,706 —
mRNAcDNA — 8,446
Mutant 4,829 1,607
Protein 88,607 60,782
Tissue — 36,029
Table 2: Entity types and counts in each corpus. A long
dash indicates that the entity was not marked in that corpus.
the pre-processing, the PPI corpus contains approximately
74.6K sentences and 2.0M tokens, and the TE corpus is
made up of around 62.8K sentences and 1.9M tokens.11
4.2 Description of Markables
In both corpora the markables, i.e. units of annotation, con-
sist of named entities, normalisations, relations, properties
and attributes.
Named entities are terms of interest to biologists which be-
long to pre-defined semantic classes. Table 2 shows the
named entity types marked and their counts in each corpus.
In the PPI corpus, the entities are either proteins and other
related entities involved in PPI relations (Protein, Complex,
Fusion, Fragment and Mutant) or attributes of PPI relations
(CellLine, DrugCompound, ExperimentalMethod, Modifi-
cation). Conversely, for the TE corpus, the entities are either
those that can be involved in TE relations (Tissue, Protein,
Complex, Fusion, Fragment, Mutant, Gene, mRNAcDNA
and GOMOP) or those that can be attributes of TE rela-
tions (DevelopmentalStage, Disease, DrugCompound, Ex-
perimentalMethod). All named entity types (except GO-
MOP) have intuitively obvious biological interpretations,
which are made precise in the annotation guidelines. For
example, the definition of DrugCompound is: “a chemical
substance of known composition used to affect the func-
tion of an organism, cell or biological process”. The GO-
MOP entity type was used in cases where the annotator felt
that the author was referring to a “Gene or mRNAcDNA or
Protein”. We felt that having a single entity type to repre-
sent this kind of ambiguity would be simpler than allowing
annotators to mark the same term as multiple entity types
(e.g. Protein and Gene).
11Note that all annotated versions of each paper are treated as
separate documents in this calculation.
Database Url Prefix PPI TE
NCBI Taxonomy http://www.ncbi.nlm.nih.gov/Taxonomy/ ncbitaxon: Protein Gene, mRNAcDNA, Protein, GOMOP
RefSeq http://www.ncbi.nlm.nih.gov/RefSeq/ refseq: Protein Protein, mRNAcDNA
EntrezGene http://www.ncbi.nlm.nih.gov/entrez/ gene: Protein Gene, mRNAcDNA, Protein, GOMOP
ChEBI http://www.ebi.ac.uk/chebi/ chebi: — DrugCompound
MeSH http://www.nlm.nih.gov/mesh/ mesh: — Tissue
Table 3: Databases used for normalisations and the entities to which they are assigned in each corpus. A long dash indicates
that the database was not used in that corpus.
Corpus Relation type Count
PPI PPI 11,523
PPI FRAG 16,002
TE TE 12,426
TE CHILD-PARENT 4,735
Table 4: Relation types in each corpus.
When marking named entities, the annotators were permit-
ted to nest them, but entities were not allowed to cross. For
any pair of entities with a non-empty intersection, the inter-
section therefore had to coincide with at least one of the en-
tities. Entities were also required to be continuous. Discon-
tinuous coordinations such as “A and B cells” were anno-
tated as two nesting entities “A and B cells” and “B cells”,
indicating that the first was discontinuous using a flag in
the XML. Furthermore, annotators were able to override the
tokenisation if entity boundaries and token boundaries did
not coincide, by indicating the entity boundaries using char-
acter offsets. For example, in one annotated document, the
term “Cdt1(193-447)” is tokenised as a single token, but the
annotator decided that “Cdt1” was a Protein and “193-447”
was a Fragment. The Protein was therefore marked using
an end offset of -9, to indicate that the end of the Protein
name was 9 characters from the end of the token, and in a
similar way the Fragment had start offset 5 and end offset
-1. The XML representation of the data enables retokeni-
sation as proposed by Grover et al. (2006) to improve the
original tokenisation at a later stage while preserving the
entity annotation.
A number of types of entities were normalised to one
or more of the standard, publicly available biomedical
databases listed in Table 3. In general, for each entity term
that was normalised, an ID of the appropriate database was
assigned as the normalisation value with a prefix indicating
the source database. If no appropriate identifier existed, the
ID was left blank and only the database prefix was used as
the normalised value.
Normalisation of protein, gene and mRNAcDNA entities
was more complex. Two types of normalisations were
added to each occurrence of such entities: full normalisa-
tion and species normalisation, where the former involves
assigning RefSeq identifiers to protein and mRNAcDNA
terms and EntrezGene identifiers to gene terms; and the lat-
ter involves assigning NCBI taxonomy identifiers to pro-
tein, gene and mRNAcDNA terms. The project initially
aimed at providing full normalisation for both corpora.12
However, full normalisation turned out to be too time-
consuming. Given limited time and resources, only the
12In fact, both RefSeq and EntrezGene identifiers are species-
specific. When a term is “fully normalised” its host species can
therefore be identified without species normalisation.
TE corpus and the DEVTEST and TEST portions of the PPI
corpus were fully normalised, while the TRAIN portion of
the PPI corpus was only species-normalised. A few special
cases must be considered in the normalisation annotation:
• Species mismatch. For the term to be normalised,
there is an entry in the database (e.g. RefSeq) which
matches the specific entity but the entry does not
match the species of the term given the surrounding
context. In this case the term was only normalised for
its species (i.e. species normalisation).
• Several host species. The term to be normalised is dis-
cussed relative to several host species. In this case, the
term was normalised multiple times and each anno-
tated entity was assigned a unique identifier for each
species mentioned. In case of more than five possible
host species for the term, annotators followed the next
instruction.
• Host species not clear. The host species of a term to
be normalised cannot be determined from the text, be-
cause it is discussed in a general way rather than in
relation to one or more specific species, or the text
is unclear about the host species of the term. In this
case, the entity was normalised as if its species was
Homo sapiens, and the keyword “gen” (for “general”)
was added to any chosen identifier, e.g. “NP 004513
(gen)”, and at the same time the Taxonomy iden-
tifier for Homo sapiens together with the keyword
“gen” (e.g., “9606 (gen)”) were entered as the species-
normalisation. However, if Homo sapiens could not
possibly be the correct host species, due to the occur-
rence of a general species word, such as viral or bac-
terial, “gen” was entered for species normalisation.
In each corpus, two types of relations were marked (see
Table 4). In the PPI corpus, relations refer to interactions
between two proteins (PPI) and connect Mutants and Frag-
ments with their parent proteins (FRAG). In the TE corpus,
relations indicate when a gene or gene product is expressed
in a particular tissue (TE); relations also connect Mutants
and Fragments with their parent proteins (CHILD-PARENT).
Annotators were permitted to mark relations between enti-
ties in the same sentence (intra-sentential) and in different
sentences (inter-sentential). For the TE and PPI relations,
annotators also marked “link terms” used by the authors to
indicate a relation. Marked in the same way as entities,
these are called InteractionWord for PPI relations and Ex-
pressionLevelWord for TE relations.
The properties and attributes are extra pieces of informa-
tion added by the annotators to both PPI and TE relations.
A property is a name-value pair assigned to a relation to add
extra information, for example whether a PPI is mentioned
Name Value PPI TE
IsPositive Positive 10,718 10,243
Negative 836 2,067
IsDirect Direct 7,599 —
NotDirect 3,977 —
IsProven Proven 7,562 9,694
Referenced 2,894 1,837
Unspecified 1,096 736
Table 5: Property names, values and counts in each corpus.
A long dash indicates that the property was not marked in
this corpus.
as being direct or indirect, or whether it was experimentally
proven in the paper. Both positive and negative TE and PPI
relations, i.e. statements asserting that an interaction or ex-
pression did or did not occur, were also marked, with prop-
erties used to distinguish between them. The names and
values for the properties were drawn from a small closed
list and annotators assigned at least one value to each name,
for each relation. Their counts in each corpus are listed in
Table 5.
Attributes are named links between relations and other enti-
ties, e.g. to indicate the experimental method used to verify
a PPI relation, or the cell line used to discover a TE relation.
In the PPI corpus, all attributes, except for MethodEntity,
are attached to entities. Conversely, all attributes are at-
tached to relations in the TE corpus. Attributes are also
used to link a relation to its link term and do not have to be
in the same sentence as the relation. The names and counts
of the attributes are listed in Tables 6 and 7.
Note that as well as being able to add multiple values for
each relation property, annotators were also permitted to
add multiple values for each attribute. They did this by
marking extra relation entries. For example, in a sentence
such as “Protein A interacts with B in the presence of Drug
C but not D.”, the annotators would mark two PPI relations
between “A” and “B”, one Positive with “C” as a Drug-
Compound attribute, and the other negative with “D” as a
DrugCompound attribute.
4.3 The Annotation Process
Annotation was performed by a group of nine biologists,
all qualified to PhD level in biology, working under the su-
pervision of an annotation manager (also a biologist) and
collaborating with a team of NLP researchers. At the be-
ginning of the annotation of each corpus, a series of discus-
sions between the biologists and the NLP team were held
with the aim of determining a set of markables. Since the
overall aim of the project was to build NLP tools for inte-
gration into a curation assistant, the markables suggested
by the biologists were those which they wished the cura-
tion assistant to aid them with. The NLP team provided in-
put as to which markables might be technically feasible and
what could be reasonably accomplished within the project
timescale.
A further consideration in selecting markables was how
well they could be annotated in practice. Markables which
could not be reliably annotated by humans would not pro-
duce good data, and as a result would be even more diffi-
cult for automated systems to extract. Using the initial list
of markables, several rounds of piloting were conducted to
determine the markables that could be annotated reliably.
For example, four piloting iterations were conducted be-
fore commencing the annotation of the PPI corpus. As a
result, it was decided to remove MutationType from the list
of originally proposed entity types as this information did
not occur frequently enough in the piloting documents. The
piloting process also helped to produce comprehensive an-
notation guidelines on all markables. During the piloting
phase, the same documents were annotated by two or three
annotators, IAA was computed for these documents, and
annotation differences were analysed. The annotators dis-
cussed points of difficulty and disagreement with the NLP
team and the annotation guidelines were clarified and ex-
tended wherever necessary.
At the end of the piloting phase a final set of markables
was agreed by all parties and the main body of annotation
commenced. During this phase weekly annotation meet-
ings were held to discuss the latest IAA measurements and
any other issues arising from the annotation, with all the an-
notators in attendance plus a representative from the NLP
team. IAA was measured using a sample of documents ran-
domly selected in advance for multiple annotation. The an-
notation was organised so that annotators were not aware
when they were assigned a document that was being an-
notated by someone else as well. When new annotators
joined the team they went through a training phase where
they annotated several documents, comparing their annota-
tions with those created by the existing team. This was done
to ensure that they were following the guidelines correctly
and were consistent with the other annotators.
For the annotation of the PPI corpus, an in-house annota-
tion tool was developed using FilemakerPro, with data be-
ing stored in a relational database before being exported to
XML for analysis by the NLP team. However, as this an-
notation tool did not scale well, a customised version of
Callisto13 was employed for the TE annotation project. Be-
fore the documents were presented to the annotators, they
were tokenised and had sentence boundaries inserted by
means of pre-processing steps implemented using the LT-
XML2 and LT-TTT2 tools. The original spacing in the docu-
ments was preserved so that it could be recovered from the
XML version simply by stripping off the word, sentence and
paragraph elements.
All annotated documents were converted to an in-house
XML format, for consumption by NLP applications. In the
XML, all annotations are placed in standoff, with the nor-
malisations included in the named entity annotation, and
the properties and attributes included in the relation anno-
tation. Listings 1, 2 and 3 show a sample of text, with its
standoff entity and relation annotation. The standoff entity
annotation uses word ids to refer to the start and end words
of the entity, and the standoff relation annotation uses entity
ids to refer to its entity pair. Note that the standoff markup
for a document and its text are contained within the same
file. An XML schema and format documentation will be
provided with the corpus release.
<s><w i d =”A33864 ”>Rrs1p</w>
<w i d =” A33870 ”>has</w> <w i d =” A33874 ”>a</w>
<w i d =” A33876 ”>two</w><w i d =” A33879 ”>−</w>
<w i d =” A33880 ”>h y b r i d</w>
<w i d =” A33887 ”> i n t e r a c t i o n</w>
<w i d =” A33899 ”>wi th</w> <w i d =” A33904 ”>L5</w>
<w i d =” A33906 ”> .</w></ s>
Listing 1: Extract from the text of an annotated document
(note the original does not contain the line breaks)
13http://callisto.mitre.org/
Name Entity type Explanation Count
ModificationBeforeEntity Modification Any modification applied before the interaction. 240
ModificationAfterEntity Modification Any modification resulting from the interaction. 1,198
DrugTreatmentEntity DrugCompound Any drug treatment applied to the interactors. 844
CellLineEntity CellLine The cell-line from which the interactor was drawn. 2,000
ExperimentalMethodEntity ExperimentalMethod The method used to detect the interactor. 1,197
MethodEntity ExperimentalMethod The method used to detect the interaction. 2,085
InteractionWordEntity InteractionWord The term which indicates the interaction. 11,386
Table 6: Attributes in the PPI corpus.
Name Entity type Explanation Count
te rel ent-drug-compound DrugCompound Any drug compound applied. 1,549
te rel ent-exp-method1 ExperimentalMethod The method used to detect the expression participants. 1,878
te rel ent-disease DiseaseType Any disease affecting the tissue. 332
te rel ent-dev-stage DevelopmentalStage The developmental stage of the tissue. 327
te rel ent-expr-word ExpressionLevelWord A term indicating the level of expression. 2,815
Table 7: Attributes in the TE corpus.
<e n t i d =” e933262 ” norm=” NP 014937 ” t y p e =” P r o t e i n ”
s p e c i e s =” 4932 ” sw=”A33864 ” ew=” A33864 ”>Rrs1p</ e n t>
<e n t i d =” e933263 ” norm=” ” t y p e =” E xpe r imen ta lM e thod ”
sw=”A33876 ” ew=” A33880 ”>two−h y b r i d</ e n t>
<e n t i d =” e933264 ” norm=” ” t y p e =” I n t e r a c t i o n W o r d ”
sw=”A33887 ” ew=” A33887 ”> i n t e r a c t i o n</ e n t>
<e n t i d =” e933265 ” norm=” NP 015194 ” conf =” 100 ”
t y p e =” P r o t e i n ” s p e c i e s =” 4932 ” sw=”A33904 ”
ew=”A33904 ”>L5</ e n t>
Listing 2: Example of standoff annotation of entities
< r e l a t i o n t y p e =” p p i ” i d =” r903106 ” I s P ro v e n =” Proven ”
I s D i r e c t =” D i r e c t ” I s P o s i t i v e =” P o s i t i v e ”>
<a rgumen t r e f =” e933262 ”></ a rgumen t>
<a rgumen t r e f =” e933265 ”></ a rgumen t>
<a t t r i b u t e name=” M ethodE nt i ty ” r e f =” e933263 ” />
<a t t r i b u t e name=” I n t e r a c t i o n W o r d E n t i t y ”
r e f =” e933264 ” />
</ r e l a t i o n>
Listing 3: Example of standoff annotation of relations
4.4 Inter-annotator Agreement
We IAA for each corpus and each markable using the mul-
tiply annotated documents. For each pair of annotations on
the same document, IAA was calculated by scoring one an-
notator against another using precision, recall and F1. For
the PPI corpus, IAA was calculated on a total of 146 doc-
ument pairs. IAA for TE corpus, having fewer triple anno-
tations, was computed over a total of 92 document pairs.
An overall corpus IAA was calculated by micro-averaging
across all annotated document pairs.14 Micro-averaging
was chosen over macro-averaging, since we felt that the lat-
ter would give undue weight to documents with few or no
markables. We used F1 rather than Kappa (Cohen, 1960)
to measure IAA since the latter requires comparison with
a random baseline, which would not make sense for tasks
such as named entity recognition and normalisation.
For named entities, IAA was calculated using precision, re-
call and F1, defining two entities as equal if they had the
same left and right boundaries, and the same type. The IAA
14Micro-averaging means giving equal weight to each example,
as opposed to macro-averaging which would give equal weight to
each annotated document pair.
Type PPI TE
CellLine 81.6 (2,456) —
Complex 76.4 (2,243) 82.6 (886)
DevelopmentalStage — 72.7 (357)
Disease — 74.3 (435)
DrugCompound 76.4 (3,705) 84.9 (4,453)
ExperimentalMethod 74.0 (4,673) 76.7 (2,013)
Fragment 75.3 (3,985) 77.7 (1,179)
Fusion 78.5 (1,270) 73.9 (359)
GOMOP — 50.2 (655)
Gene — 77.7 (1,911)
Modification 87.6 (1,900) —
mRNAcDNA — 78.1 (1,768)
Mutant 60.4 (1,008) 63.9 (310)
Protein 91.6 (32,799) 90.3 (16,329)
Tissue — 84.1 (8,210)
All 84.9 (54,039) 83.8 (38,865)
Table 8: IAA for entities (in F1) in each corpus. The total
number of true positives is shown in brackets.
figures for named entities listed in Table 8 show that an-
notation consistency is generally high, with important and
frequently occurring entities scoring in the 80s or 90s. IAA
is low for entity types which occur infrequently such as
Mutant. It is particularly low for GOMOP, not only an
infrequent entity but also an artificially constructed class
designed to include cases of annotator uncertainty. The
overall IAA is lower than that normally reported for MUC
type entities, but fits with our observations that biomedical
named entity annotation is more difficult.
The IAA for normalisations was only calculated when both
annotators agreed on the entities. This means that the nor-
malisation IAA only reflects agreement on normalisation
annotation and is not affected by the level of agreement
on the entity annotation. In addition, all entities marked
as general were excluded from the IAA calculations (see
Table 9). For Protein and mRNAcDNA types, only those
entities that were normalised to RefSeq identifiers were
included in the IAA calculations while for Gene and GO-
MOP entities, only those entities normalised to EntrezGene
identifiers were included. The IAA was measured using F1
where two normalisations were considered equal if both an-
Type PPI TE
DrugCompound — 97.7 (215)
GOMOP — 77.3 (214)
Gene — 95.1 (1,463)
mRNAcDNA — 88.0 (892)
Protein 88.4 (7,595) 90.0 (5,979)
Tissue — 82.9 (6,776)
All 88.4 (7,595) 83.8 (15,785)
Table 9: IAA for normalisation (in F1) in each corpus. The
total number of true positives is shown in brackets.
Type PPI TE
PPI 67.0 (2,729) —
TE — 70.1 (2,078)
FRAG 84.6 (3,661) 84.0 (1,012)
All 76.1 (6,390) 74.1 (3,090)
Table 10: The IAA for relations (in F1) in each corpus. The
total number of true positives is shown in brackets. Note
that FRAG relations are referred to as CHILD-PARENT in
the TE corpus.
notators selected the same ID.
When calculating IAA for relations, only those relations for
which both annotators agreed on the entities were included.
Relation IAA was also measured using F1, where relations
are counted as equal if they connect exactly the same en-
tity pair, and have the same type. The IAA for relations
shown in Table 10 is overall lower than that for entities and
normalisations, suggesting that this is a more difficult task.
Since relations can span across clauses and even across sen-
tences, the annotators need to perform a deeper analysis of
the text than for entity annotations.
For properties, IAA was calculated for each name-value
pair, again using precision, recall and F1. In cases where
the annotators had entered multiple relations of the same
type between the same entities, these sets of equivalent re-
lations were collapsed for the purpose of property and at-
tribute IAA calculation. The collapsed relation was given
the union of all the properties and attributes assigned to the
relations in the set. This collapsing is an approximation of
the annotator’s intentions, but the number of occurrences
of multiple equivalent relations is small so the collapsing
should not have a significant effect on the IAA. The IAA
for properties shown in Table 11 is generally very high, ex-
cept for the IsProven-Unspecified category which was used
infrequently by the annotators and suffers from being an
“other” category.
For attributes, IAA was again measured using precision, re-
call and F1. Two attributes were considered equivalent if
they had the same type and connected the same relation
and entity. Tables 12 and 13 show the IAA figures for at-
tributes. These are quite low in some cases, and so are the
total numbers of attributes assigned. Investigation of the
IAA suggests that annotators often disagreed about whether
to assign an attribute or not, but if they both assigned an
attribute then they generally chose the same one. The en-
tities used as attributes sometimes appeared at a distance
from the relation in the text. Therefore, it is not surprising
that annotators sometimes missed them, or assigned them
inconsistently.
Name Value PPI TE
IsPositive Positive 99.6 (2,553) 97.2 (1,807)
Negative 90.1 (155) 88.9 (280)
IsDirect Direct 86.8 (1,746) —
NotDirect 61.4 (449) —
IsProven Proven 87.8 (1,543) 92.8 (1,547)
Referenced 88.6 (626) 75.3 (204)
Unspecified 34.4 (448) 29.3 (38)
All 87.2 (7.165) 91.2 (3,779)
Table 11: IAA for properties (in F1) in each corpus. The
total number of true positives is shown in brackets.
Name IAA
ModificationBeforeEntity 65.3 (31)
ModificationAfterEntity 86.7 (248)
DrugTreatmentEntity 45.4 (61)
CellLineEntity 64.0 (244)
ExperimentalMethodEntity 36.9 (94)
MethodEntity 55.4 (274)
All 59.6 (952)
Table 12: IAA of attributes (in F1) in the PPI corpus. The
total number of true positives is shown in brackets.
Name IAA
te rel ent-drug-compound 77.9 (229)
te rel ent-exp-method1 81.3 (261)
te rel ent-disease 64.0 (16)
te rel ent-dev-stage 57.8 (13)
All 77.2 (521)
Table 13: IAA of attributes (in F1) in the TE corpus. The
total number of true positives is shown in brackets.
5 Discussion and Conclusions
In terms of the amount of text annotated, the ITI TXM cor-
pora are the result of one of the largest biomedical corpus
annotation projects attempted to date. The two domains
covered (protein-protein interactions and tissue expression)
are both of crucial importance to biologists. Although there
are several corpora already available with annotations of
PPI, most of these only include protein annotation, and do
not include the range of entities and normalisations avail-
able in the ITI TXM corpora. There are few available an-
notated corpora addressing tissue expression, and we are
unaware of any large-scale efforts whose main focus is that
domain.
Another interesting aspect of the ITI TXM corpora is the
annotation of normalisations for multiple types of entity
mentions, and for multiple species. This annotation was
motivated by the role of the NLP system, as an assistant to
curators, as it was suspected that mapping proteins, genes
and other terms to standard databases occupied a signifi-
cant proportion of curators’ time. The annotation of multi-
species normalisations was difficult in situations where it
was unclear which species was being referred to for a given
named entity mention. These issues were resolved by de-
riving a series of annotation guidelines, as detailed in Sec-
tion 4.2. The annotation guidelines were also reasonably
successful in ensuring annotator consistency, as evidenced
by the normalisation IAA provided in Section 4.4.
During the annotation we found that the interaction be-
tween the NLP team and the biologists was essential at all
stages. In the design phase, the biologists, as the domain
experts, provided insight into what information should be
annotated. At the same time, the NLP team were able to ex-
plain to the biologists what their technology is capable of.
However, although both parties have an insight into what
can be reliably annotated, the only sure way to determine
this is empirically through extensive piloting. The piloting
phase not only provided experimental data on annotation
agreement and timing, but also helped the NLP team and
the biologists to improve their shared understanding of the
annotation process and its difficulties. During the main an-
notation phase, it was helpful to have regular contact be-
tween the NLP and the annotation teams in order to ensure
that doubts and difficulties were noted, discussed and re-
solved as quickly as possible. The NLP team analysed the
data as it was produced by the annotators and drew their
attention to any recurring sources of disagreement.
We believe that measuring IAA is a crucial part of any cor-
pus annotation effort. It provides a check that the annotators
are producing a reliable and consistent corpus. It also gives
a measure of how difficult the task is and suggests how well
an automated system can be expected to perform. We took
steps to ensure that the IAA itself was reliable, by instruct-
ing annotators not to discuss papers whilst annotating them.
We also did not inform annotators in advance whether they
were working on a paper that was also being annotated by
another person. The IAA measurements for the final set
of markables shows that some proved difficult to annotate
reliably, for example the GOMOP entity and some of the
attributes. Annotating them was problematic in the piloting
phase, and whilst we attempted to tighten up the guidelines,
it was not sufficient to boost their IAA.
We hope that the two ITI TXM corpora, consisting of over
200 papers each, and with multiple types of semantic an-
notation, will provide a useful resource for the biomedical
text-mining community when released to the academic re-
search community later this year.
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